Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201306103 Principal Investigator: Ademuyiwa, Foluso
Title: A Phase I Dose Escalation Study of POL6326 with Eribulin in Patients with Relapsed, Triple Negative and Hormone Refractory ER Positive Metastatic Breast Cancer
Phase: I/II Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The CXCR4/CXCL12 axis is important in metastatic breast cancer with regard to proliferation, invasiveness and metastasis,
particularly cell homing to, and survival in, distant sites including lung, liver, bone, and bone marrow.
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)